prop rearview mirror
mix quarter core perform track
report adj ep estimate
consensu core oper perform larg track coupl item
weigh earn lower high end adjust oper incom
guidanc midpoint reflect increment advocaci cost
chang compani execut retir polici compani
see anyth unusu manag care negoti posit see
slight declin commerci mix small shift toward lower pay plan
comment could weigh result given fm issu quarter given number
item guidanc see reason adjust baselin
grow core earn make consensu outlook appear
achiev even though guidanc reduc prop profit cap ballot
initi rearview mirror investor shift focu back next potenti
catalyst sale davita medic group dmg signific capit
deploy estim could repurchas stock next
month adjust ebitda estim cut rais
unchang po base ebitda vs previous new
estimate reflect better growth prospect reiter buy rate upsid capit
deploy remain top hc facil pick
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter provid potenti bridg growth review dva
capit deploy option estim compani could see adjust
oper incom growth meanwhil could repurchas third
market cap drive signific sharehold return remain excit dva
capit catalyst look color close davita medic group dmg
sale come month
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
davita inc lead dialysi provid
unit state compani oper
outpati clinic us serv
patient also oper countri
outsid us
commerci mix price stabil bode
well core busi addit continu
view sale davita medic group dmg
posit potenti use
proce share repurchas debt
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter provid potenti bridg growth review dva
capit deploy option estim compani could see adjust
oper incom growth meanwhil could repurchas third
market cap drive signific sharehold return remain excit dva
capit catalyst look color close davita medic group dmg
sale come month
reason bridg
provid potenti adjust oper incom bridg analysi
factor volum rate cost outlook compani head
estim could see adjust oper incom growth
organ volum line dva outlook capit market
day may although compani may end toward low end
rang given recent volum trend
total volum line dva outlook impli
impact acquisit would comfort low end
govern rate line dialysi medicar rate updat
essenti increas past five year
commerci rate payer get increment
aggress price
blend price within outlook outlin given
strong medicar rate updat
labor toward high end outlook outlin
compani see increment labor pressur strong economi
cost outlook outlin
 corpor line treatment growth
impli adjust oper incom growth vs
rang provid capit market day may
guidanc low end previou rang driven
spent advocaci chang compani execut
adjust baselin add back prop advocaci cost
management retir cost davita rx headwind meanwhil also subtract
medicar bad debt recoveri davita health solut dh benefit
earlier year
normal mb medicar
 corpor
line tx
labor cost rise
guid teammat cost growth per treatment capit market
day compani highlight labor cost growth
final compani guid teammat cost growth
given strong economi think prudent assum labor cost inflat toward
upper end rang
tabl teammat cost per treatment capit market day
remain bullish dva substanti capit flexibl follow close
davita medic group dmg sale factor cash avail cash hand
forecast billion tax proce deal billion
estim billion total cash deploy remaind
net leverag would impli compani could repurchas
stock year end meanwhil net leverag could repurchas
stock time period overal dva capit posit appear particularli
posit compani repurchas third market cap
remain within leverag target
tabl potenti share repurchas differ leverag scenario
total cash deploy share repo
note compani continu work toward close deal year end
acknowledg time could slip meanwhil quarter
compani made reserv adjust fair valu dmg cut valuat
million ask call compani indic reserv
chang merger agreement term impli net proce number
remain unchang close dmg sale time next potenti catalyst
conclus stori track top hc facil pick
even recent ralli prop dialysi profit cap defeat still see lot
upsid oper perform remain track see signific
potenti buyback compani could repurchas third market cap
year end reiter buy rate remain top hc
po base ebitda estim high end
stand-alon histor rang ebitda commerci outlook
stabil dmg sale allow focu core dialysi busi
upsid risk po commerci mix better expect
reimburs better expect make chang third
downsid risk po commerci price pressur could continu
potenti commerci mix pressur manag care vast major dialysi
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
